Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-12

Clinical Trial Update: Optic Nerve Perfusion Following Treatment with Latanoprost Versus Brimionidin Tartrate [EARLY_Phase 1]

View source ↗

Summary

A completed early-phase trial comparing optic nerve perfusion after treatment with latanoprost versus brimonidine tartrate in glaucoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIMONIDINE TARTRATE (brimonidine tartrate)
  • Latanoprost (Latanoprost)

Snippet

Sponsor: Zagazig University | Conditions: Glaucoma | EARLY_Phase 1 | Status: COMPLETED